Table 2.
Initial Protocol (57 L, 30 mg/mL NP) | Current Protocol (114 L, 15 mg/mL NP) | ||||||
---|---|---|---|---|---|---|---|
Exposure | Biological Replicate | RNA Quantity (g/L) | OD 260/280 | OD 260/230 | RNA Quantity (g/L) | OD 260/280 | OD 260/230 |
1 | 89.04 | 1.66 | 1.84 | 32.31 | 2.09 | 2.09 | |
2 | 7.99 | 2.25 | 0.46 | 55.30 | 2.01 | 1.80 | |
HO | 3 | 121.07 | 2.12 | 1.14 | 69.60 | 2.13 | 2.18 |
4 | 206.30 | 2.04 | 2.32 | 16.09 | 2.08 | 1.43 | |
5 | / | / | / | 48.94 | 2.18 | 1.98 | |
1 | 3.30 | 1.86 | 0.26 | 3.61 | 1.83 | 3.72 | |
2 | 96.96 | 2.03 | 1.81 | 61.96 | 2.14 | 2.16 | |
TiO NP | 3 | 8.01 | 2.48 | 51.25 | 91.57 | 1.99 | 2.05 |
4 | 134.43 | 2.08 | 1.55 | 58.93 | 2.10 | 2.02 | |
5 | / | / | / | 66.30 | 2.06 | 2.17 | |
Mean | 83.61 | 2.07 | 1.33 | 50.46 | 2.06 | 2.16 | |
SD | 73.27 | 0.24 | 0.70 | 26.34 | 0.10 | 0.59 |